Overview

Xtandi (enzalutamide) is a medication used primarily in the treatment of prostate cancer. As an androgen receptor inhibitor, Xtandi works by blocking the effects of androgens (male hormones), which can stimulate the growth of prostate cancer cells. The medication is highly effective but comes with a significant cost, making its price a critical consideration for many patients and healthcare systems.